JP2022545568A5 - - Google Patents
Info
- Publication number
- JP2022545568A5 JP2022545568A5 JP2022521405A JP2022521405A JP2022545568A5 JP 2022545568 A5 JP2022545568 A5 JP 2022545568A5 JP 2022521405 A JP2022521405 A JP 2022521405A JP 2022521405 A JP2022521405 A JP 2022521405A JP 2022545568 A5 JP2022545568 A5 JP 2022545568A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- vitiligo
- week
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075642A JP2024105436A (ja) | 2019-06-10 | 2024-05-08 | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
Applications Claiming Priority (25)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962859584P | 2019-06-10 | 2019-06-10 | |
| US201962859506P | 2019-06-10 | 2019-06-10 | |
| US201962859601P | 2019-06-10 | 2019-06-10 | |
| US201962859495P | 2019-06-10 | 2019-06-10 | |
| US201962859532P | 2019-06-10 | 2019-06-10 | |
| US62/859,532 | 2019-06-10 | ||
| US62/859,495 | 2019-06-10 | ||
| US62/859,584 | 2019-06-10 | ||
| US62/859,506 | 2019-06-10 | ||
| US62/859,601 | 2019-06-10 | ||
| US201962894514P | 2019-08-30 | 2019-08-30 | |
| US201962894541P | 2019-08-30 | 2019-08-30 | |
| US201962894564P | 2019-08-30 | 2019-08-30 | |
| US201962894581P | 2019-08-30 | 2019-08-30 | |
| US201962894496P | 2019-08-30 | 2019-08-30 | |
| US62/894,581 | 2019-08-30 | ||
| US62/894,496 | 2019-08-30 | ||
| US62/894,514 | 2019-08-30 | ||
| US62/894,541 | 2019-08-30 | ||
| US62/894,564 | 2019-08-30 | ||
| US201962911845P | 2019-10-07 | 2019-10-07 | |
| US62/911,845 | 2019-10-07 | ||
| US202062967879P | 2020-01-30 | 2020-01-30 | |
| US62/967,879 | 2020-01-30 | ||
| PCT/US2020/036985 WO2020252012A1 (en) | 2019-06-10 | 2020-06-10 | Topical treatment of vitiligo by a jak inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075642A Division JP2024105436A (ja) | 2019-06-10 | 2024-05-08 | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545568A JP2022545568A (ja) | 2022-10-27 |
| JP2022545568A5 true JP2022545568A5 (https=) | 2023-06-20 |
| JP7532511B2 JP7532511B2 (ja) | 2024-08-13 |
Family
ID=73651112
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521405A Active JP7532511B2 (ja) | 2019-06-10 | 2020-06-10 | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
| JP2024075642A Pending JP2024105436A (ja) | 2019-06-10 | 2024-05-08 | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075642A Pending JP2024105436A (ja) | 2019-06-10 | 2024-05-08 | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20200405627A1 (https=) |
| EP (1) | EP3982971A4 (https=) |
| JP (2) | JP7532511B2 (https=) |
| AU (2) | AU2020290995B2 (https=) |
| CA (1) | CA3150975A1 (https=) |
| IL (1) | IL290637A (https=) |
| MA (1) | MA56215A (https=) |
| TW (1) | TW202112377A (https=) |
| WO (1) | WO2020252012A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102821964B1 (ko) | 2017-11-03 | 2025-06-19 | 어클라리스 쎄라퓨틱스, 인코포레이티드 | 치환된 피롤로피리미딘 jak 억제제 및 이의 제조 및 사용 방법 |
| CN119080779A (zh) | 2018-08-10 | 2024-12-06 | 阿克拉瑞斯治疗股份有限公司 | 吡咯并嘧啶itk抑制剂 |
| JP7532511B2 (ja) | 2019-06-10 | 2024-08-13 | インサイト・コーポレイション | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
| WO2022061351A1 (en) * | 2020-09-16 | 2022-03-24 | Incyte Corporation | Topical treatment of vitiligo |
| TW202302104A (zh) * | 2021-02-18 | 2023-01-16 | 美商阿克拉里斯醫療股份有限公司 | Jak 1/3抑制劑的局部配方及其用於治療異位性皮膚炎和其他皮膚狀況之用法 |
| CN117279915A (zh) * | 2021-02-18 | 2023-12-22 | 阿克拉瑞斯治疗股份有限公司 | Jak1/3抑制剂的局部制剂及其用于特异性皮炎和其他皮肤病况的治疗的方法 |
| EP4389114A4 (en) * | 2021-08-19 | 2025-09-03 | Zhuhai United Laboratories Co Ltd | LOCAL TOPICAL FORMULATION CONTAINING A JAK INHIBITOR OR A SALT THEREOF OR A CRYSTALLINE FORM THEREOF, PREPARATION METHOD THEREOF AND CORRESPONDING APPLICATION |
| CN115869321A (zh) | 2021-09-28 | 2023-03-31 | 杭州中美华东制药有限公司 | 一种芦可替尼组合物及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| PT1107964E (pt) | 1998-08-11 | 2010-06-11 | Novartis Ag | Derivados de isoquinolina com actividade inibidora da angiogénese |
| US6133031A (en) | 1999-08-19 | 2000-10-17 | Isis Pharmaceuticals Inc. | Antisense inhibition of focal adhesion kinase expression |
| GB9905075D0 (en) | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
| GB0004890D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| BR0212760A (pt) | 2001-09-19 | 2004-12-07 | Aventis Pharma Sa | Compostos quìmicos |
| DE60213842T2 (de) | 2001-10-30 | 2007-09-06 | Novartis Ag | Staurosporin-derivate als hemmer der flt3-rezeptor-tyrosinkinase-wirkung |
| PE20040522A1 (es) | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| EP1542768A1 (en) | 2002-09-20 | 2005-06-22 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
| UA80767C2 (en) | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| GB0305929D0 (en) | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| AR045944A1 (es) | 2003-09-24 | 2005-11-16 | Novartis Ag | Derivados de isoquinolina 1.4-disustituidas |
| AU2005309019A1 (en) | 2004-11-24 | 2006-06-01 | Novartis Ag | Combinations of JAK inhibitors and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitors |
| SG10202003901UA (en) | 2005-12-13 | 2020-05-28 | Incyte Holdings Corp | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| KR20150036210A (ko) | 2007-06-13 | 2015-04-07 | 인사이트 코포레이션 | 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염 |
| PE20130216A1 (es) | 2010-05-21 | 2013-02-27 | Incyte Corp | Formulacion topica para un inhibidor de jak |
| AU2017358703A1 (en) | 2016-11-10 | 2019-05-09 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases |
| US11957931B2 (en) | 2017-04-26 | 2024-04-16 | Yale University | Compositions and methods for treating vitiligo |
| US20190060311A1 (en) | 2017-08-24 | 2019-02-28 | Aclaris Therapeutics, Inc. | Compositions and methods for treatment of vitiligo |
| MA52655A (fr) | 2018-03-30 | 2021-02-17 | Incyte Corp | Biomarqueurs pour maladie cutanée inflammatoire |
| CN111374639A (zh) | 2018-12-28 | 2020-07-07 | 陈柏龄 | 败血症的菌种预测系统与方法 |
| US20210030672A1 (en) | 2019-06-10 | 2021-02-04 | Incyte Corporation | Topical treatment of vitiligo by a jak inhibitor |
| JP7532511B2 (ja) * | 2019-06-10 | 2024-08-13 | インサイト・コーポレイション | Ｊａｋ阻害剤による尋常性白斑の局所治療 |
-
2020
- 2020-06-10 JP JP2022521405A patent/JP7532511B2/ja active Active
- 2020-06-10 US US16/897,927 patent/US20200405627A1/en not_active Abandoned
- 2020-06-10 EP EP20823024.3A patent/EP3982971A4/en active Pending
- 2020-06-10 AU AU2020290995A patent/AU2020290995B2/en active Active
- 2020-06-10 CA CA3150975A patent/CA3150975A1/en active Pending
- 2020-06-10 US US16/897,923 patent/US11602536B2/en active Active
- 2020-06-10 MA MA056215A patent/MA56215A/fr unknown
- 2020-06-10 WO PCT/US2020/036985 patent/WO2020252012A1/en not_active Ceased
- 2020-06-10 TW TW109119535A patent/TW202112377A/zh unknown
-
2022
- 2022-02-15 IL IL290637A patent/IL290637A/en unknown
- 2022-07-08 US US17/860,884 patent/US11590138B2/en active Active
- 2022-12-08 US US18/077,315 patent/US12233067B2/en active Active
-
2024
- 2024-05-08 JP JP2024075642A patent/JP2024105436A/ja active Pending
-
2026
- 2026-01-21 AU AU2026200410A patent/AU2026200410A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545568A5 (https=) | ||
| Mawdsley | Treatment of Parkinsonism with Laevo-dopa | |
| US9782438B2 (en) | Method of promoting hair growth by administration of BFGF | |
| US12233067B2 (en) | Topical treatment of vitiligo by a JAK inhibitor | |
| JPH0653681B2 (ja) | 体重の選択的減量のための組成物 | |
| KR20190084028A (ko) | 두개 신경의 약리학적 피부 활성화에 의한 신경변성 질환과 관련된 증상의 치료 | |
| Fischer et al. | Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat | |
| Ross et al. | Effects of topically applied isoproterenol on aqueous dynamics in man | |
| Brown et al. | Systemic complications associated with retinal cryoablation for retinopathy of prematurity | |
| WINTON | Anesthesia for dermatologic surgery | |
| US4608365A (en) | Treatment of neurologic functions | |
| US20210030672A1 (en) | Topical treatment of vitiligo by a jak inhibitor | |
| WO2001000196A2 (en) | Mirtazapine for weight gain in wasting diseases | |
| West et al. | Sudden hypotension associated with midazolam and sufentanil | |
| US20240189382A1 (en) | Formula for inhibiting aging regeneration repair | |
| HUP0100599A2 (hu) | Lokális anesztetikumok új alkalmazása vaszkuláris fejfájások ellen | |
| JP2023542137A5 (https=) | ||
| US12390426B1 (en) | Use of adamantane compositions and methods of reducing fibrotic tissue | |
| Luduena et al. | 2-phenyl-4-thiazolidone derivatives as local anesthetics | |
| RU2638271C1 (ru) | Способ коррекции и профилактики возрастных изменений кожи лица | |
| Winkelman et al. | Prostigmin in the Treatment of Myasthenia Gravis and Muscular Dystrophy: Results Obtained with Divided Doses | |
| AU611961B2 (en) | Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis | |
| JP2011506413A (ja) | 瘢痕化阻害の方法 | |
| Akinyemi et al. | Evaluation of the perioperative analgesic effects of caudal block for herniotomy in children at the University College Hospital Ibadan, Nigeria | |
| US20230293431A1 (en) | Topical treatment of vitiligo by a jak inhibitor |